# Saguaro Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/saguaro-biosciences

- Industry: Biotechnology
- Headquarters: Quebec, Canada
- Website: www.saguarobio.com
- Total disclosed funding: $3M
- Latest round: Seed (Jun 4, 2024)
- Investors on record: 4

## About

Based in Quebec, Canada, and founded in 2020, Saguaro Biosciences operates as a provider of cell culture products, intended to help scientists enhance the success of their drug discoveries. In June 2024, Saguaro Biosciences raised USD 3 million in seed funding co-led by new investors AQC Capital and Anges Québec, with participation from other new investors Investissement Quebec and Ministère Économie, Science, Innovation du Québec. Individual and other unspecified investors also participated in the round.

Saguaro Technologies Inc. develops and offers cell culture products, that assist drug developers to generate predictive data regarding the results of clinical trials with humans, allowing them to increase the success rate of drug discoveries from their “In-vitro” models. The company’s offerings include AlphaMatrix 3D hydrogel, a defined matrix intended to compare the 3D culture results, ChromaLive non-toxic dyes, for extracting new data regarding cell biology, and PrimaFeed culture medium, a defined matrix for ensuring the results of primary tumor cell cultures.

Saguaro Biosciences intends to use the June 2024 funding for the full-scale launch of its technologies.

## Funding rounds

- Seed, Jun 4, 2024, $3M — Investment Quebec, Ministère Économie, Science, Innovation du Québec, AQC Capital, Anges Québec

## Investors

- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Seed
- Ministère Économie, Science, Innovation du Québec — Seed
- AQC Capital (https://capitalatlas.ai/funds/aqc-capital) — Seed
- Anges Québec — Seed